← All stocks

ResMed|

RMD Scheduled selling only
CIK 0000943819 #393 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$24.24M
$6.94M on a plan · $17.30M straight out of an exercise
Sold at will
$0.00
0 of 33 sales
Net
−$24.24M
$0.00 against sales at will

By person

16 insiders · 34 transactions
85.8×

Michael Farrell holds 85.8 times base salary in stock. $104.18M of shares against $1.21M in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Farrell last reported holding, valued at $222.44, the price ResMed Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Farrell Michael J.
Chairman and CEO
$15.74M (12) scheduled
−$15.74M
468,346
0.3247%
$104.18M
0.0%
FARRELL PETER C
Director
$5.01M (8) scheduled
−$5.01M
51,803
0.0359%
$11.52M
−40.6%
Sandercock Brett
Chief Financial Officer
$2.79M (7) scheduled
−$2.79M
83,495
0.0579%
$18.57M
−13.9%
De Witte Jan
Director
$645.90K (2) scheduled
−$645.90K
4,261
0.0030%
$947.81K
−43.3%
Rider Michael J
Global General Counsel
$64.73K (4) scheduled
−$64.73K
9,488
0.0066%
$2.11M
−11.5%
Leong Justin
Chief Product Officer
29,028
0.0201%
$6.46M
+4.1%
TAYLOR RONALD R
Director
24,771
0.0172%
$5.51M
+9.5%
Ghoshal Kaushik
Chief Commercial Officer, SaaS
19,353
0.0134%
$4.30M
−11.3%
SULPIZIO RICHARD
Director
17,796
0.0123%
$3.96M
+6.5%
Gill Harjit
Director
10,940
0.0076%
$2.43M
+22.2%
Drexler Karen
Director
10,602
0.0073%
$2.36M
+25.5%
Tan Desney
Director
6,002
0.0042%
$1.34M
+56.1%
Hernandez John
Director
5,118
0.0035%
$1.14M
+72.8%
DelOrefice Christopher
Director
2,423
0.0017%
$538.97K
+807.5%
Burt Carol
Director
2,156
0.0015%
$479.58K
Mowad-Nassar Nicole
Director
777
0.0005%
$172.83K
Insider
Date
Role
Action
Shares
Price
Amount
Farrell Michael J.
8 Sep 2026
Chairman and CEO
Sold after exercise
4,991
$222.44
$1.11M
Farrell Michael J.
7 Aug 2026
Chairman and CEO
Sold after exercise
4,991
$205.69
$1.03M
Farrell Michael J.
7 Jul 2026
Chairman and CEO
Sold after exercise
4,991
$218.55
$1.09M
Farrell Michael J.
8 Jun 2026
Chairman and CEO
Sold after exercise
4,991
$193.96
$968.06K
Farrell Michael J.
7 May 2026
Chairman and CEO
Sold after exercise
4,991
$207.82
$1.04M
Farrell Michael J.
7 Apr 2026
Chairman and CEO
Sold after exercise
4,991
$225.50
$1.13M
Farrell Michael J.
9 Mar 2026
Chairman and CEO
Sold after exercise
4,991
$251.03
$1.25M
Farrell Michael J.
9 Feb 2026
Chairman and CEO
Sold after exercise
4,991
$273.78
$1.37M
Farrell Michael J.
7 Jan 2026
Chairman and CEO
Sold after exercise
4,991
$248.46
$1.24M
Farrell Michael J.
8 Dec 2025
Chairman and CEO
Sold after exercise
4,991
$251.41
$1.25M
Farrell Michael J.
7 Nov 2025
Chairman and CEO
Sold after exercise
8,011
$249.75
$2.00M
Sandercock Brett
3 Nov 2025
Chief Financial Officer
Sold after exercise
3,000
$247.54
$742.62K
Farrell Michael J.
7 Oct 2025
Chief Executive Officer
Sold after exercise
8,009
$282.85
$2.27M
Sandercock Brett
1 Oct 2025
Chief Financial Officer
Sold after exercise
3,000
$274.36
$823.08K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 19
Sales straight out of an exercise 14
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 133,716
History held since 8 Sep 2016